Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

Visualizza tutta la documentazione

18858

Supelco

5-Aminosalicylic acid

analytical standard

Sinonimo/i:

5-AS, 5-Amino-2-hydroxybenzoic acid, Mesalamine

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula condensata:
H2NC6H3-2-(OH)CO2H
Numero CAS:
89-57-6
Peso molecolare:
153.14
Beilstein:
2090421
Numero CE:
201-919-1
Numero MDL:
MFCD00007877
Codice UNSPSC:
41116107
ID PubChem:
329751750
NACRES:
NA.24

Grado

analytical standard

Livello qualitativo

100

Saggio

≥98.5% (NT)
≥99.0% (GC)

Durata

limited shelf life, expiry date on the label

tecniche

HPLC: suitable
gas chromatography (GC): suitable

Impurezze

≤0.5% water

Punto di fusione

275-280 °C (dec.) (lit.)

applicazioni

pharmaceutical

Formato

neat

Temperatura di conservazione

2-8°C

Stringa SMILE

Nc1ccc(O)c(c1)C(O)=O

InChI

1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)
KBOPZPXVLCULAV-UHFFFAOYSA-N

Informazioni sul gene

human ... ALOX5(240) , PPARG(5468) , PTGS1(5742) , PTGS2(5743)

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Applicazioni

5-Aminosalicylic acid is a peroxidase substrate suitable for use in ELISA procedures. This substrate produces a soluble end product that is brown in color and can be read spectrophotometrically at 450 nm. The reaction may be stopped with 3 N NaOH and read at 550 nm.
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Pittogrammi

Exclamation mark
GHS07

Avvertenze

Warning

Indicazioni di pericolo

H315,H317,H319,H335

Classi di pericolo

Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

Organi bersaglio

Respiratory system

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 2

Punto d’infiammabilità (°F)

No data available

Punto d’infiammabilità (°C)

No data available

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number
BCCB1643
BCBS1407V

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 4

1 of 4

Sulfasalazine British Pharmacopoeia (BP) Reference Standard

BP779

Sulfasalazine

Sulfasalazine 97.0-101.5%

Sigma-Aldrich

S0883

Sulfasalazine

5-metossitriptamina 97%

Sigma-Aldrich

286583

5-metossitriptamina

4-Aminosalicylic acid 99%

Sigma-Aldrich

A79604

4-Aminosalicylic acid

Grzegorz Garbacz et al.
The Journal of pharmacy and pharmacology, 67(2), 199-208 (2015-01-06)
For the treatment of inflammatory bowel disease, the development of pH responsive modified release dosage forms is one of the most common approaches to achieve targeted drug delivery. In this study, the dissolution behaviour of eight different modified release (MR)
Rosario Cuomo et al.
United European gastroenterology journal, 2(5), 413-442 (2014-11-02)
The statements produced by the Consensus Conference on Diverticular Disease promoted by GRIMAD (Gruppo Italiano Malattia Diverticolare, Italian Group on Diverticular Diseases) are reported. Topics such as epidemiology, risk factors, diagnosis, medical and surgical treatment of diverticular disease (DD) in
W J Sandborn et al.
Alimentary pharmacology & therapeutics, 41(5), 409-418 (2015-01-16)
Conventional oral corticosteroids are effective at reducing inflammation associated with ulcerative colitis (UC); however, systemic adverse effects limit their use. Budesonide MMX is an extended-release, second-generation corticosteroid that targets delivery of budesonide to the entire colon. To analyse efficacy and
Alan C Moss et al.
The American journal of gastroenterology, 109(12), 1850-1855 (2014-06-11)
Poor adherence to mesalamine is common and driven by a combination of lifestyle and behavioral factors, as well as health beliefs. We sought to develop a valid tool to identify barriers to patient adherence and predict those at risk for
Natalia Pedersen et al.
Inflammatory bowel diseases, 20(12), 2276-2285 (2014-09-24)
To individualize treatment with mesalazine for ulcerative colitis relapses through a self-managed, web-based solution to optimize the short-term disease course. Prospective, open-label, web-guided study with 3 months mesalazine therapy among patients with mild-to-moderate ulcerative colitis. Once a week, patients completed
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.